Norway - 86 companies

BIOTECHNOLOGY-PHARMA-CHEMICAL COMPANIES IN EUROPE
Companies  721
Companies  645
Companies  509
Companies  470
Companies  278
Companies  238
Companies  106
Companies  129
Companies   98
Companies    86
Companies    96
Companies    92
Companies    76
Companies    61
Companies    61
Companies    31
Companies      0
Companies    25
Companies    14
Companies    31
Companies    12
Companies      6
Companies      4
Companies      4
Companies      2
Companies      3
Companies      7
Companies      0
Companies      0
Companies      0
Companies      0
Companies      0
Companies      0
Companies      0
Companies      0
Companies      1
Companies      0

BIOTECHNOLOGY-PHARMA-CHEMICAL WORLD COMPANIES

ON BIOTECHNOLOGY EUROPE
Companies      1
Companies      3
Companies      1
Companies      2
 
     
   
 
08.07.2008 MediGene puts clinical phase I study with RhuDex® on hold
 
07.07.2008 Early findings show promise as AS1411 AML study proceeds to higher-dose stage
 
01.07.2008 Oxford Biomedica Response to Bavarian Nordic’s US Litigation
 
01.07.2008 Oxford Biomedica Announces update on board changes
 
27.06.2008 AFINION HbA1c patent granted in USA
 
25.06.2008 An Update to Dako's Autostainer Link
 
24.06.2008 MediGene to Present at the Piper Jaffray Conference in London
 
20.06.2008 MediGene to Present at the Piper Jaffray Conference in London
 
19.06.2008 Interim Results For The Six Months Ended 31 March 2008
 
19.06.2008 Merck Applies to Extend Use of Erbitux for First-Line Head and Neck Cancer in Europe
 

05.06.2008 Novel Investigational Regimen Combining Radiation Enhancing Agent With Ibritumomab Tiuxetan (Zevalin(R)) Produces High Rate of Complete Responses in Patients With Rituximab-Refractory Follicular Non-Hodgkin's Lymphoma
 

05.06.2008 Merck Announces Initiation of Second Phase II/III Clinical Study of Atacicept in Lupus
 

02.06.2008 MediGene Focuses its Strategy on Oncology and Immunology